Home | Sitemap | Submit Content | Contact Us   
imageHome : Latest News : Sanofi’s Experimental Oral MS Treatment Cut Relapses - BusinessWeek

Sanofi’s Experimental Oral MS Treatment Cut Relapses - BusinessWeek

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service35 times read : Adjust font size: Decrease font Enlarge font
image

(Updates with comment from company in second paragraph.) Aug. 30 (Bloomberg) -- Sanofi-Aventis SA’s experimental oral medicine teriflunomide significantly reduced the relapse rate in multiple sclerosis ...

Read this article...



Post your comment comment Comments (0 posted)

copyright